Voronoi, Inc. engages in the manufacture of novel kinase inhibitors and target protein degrader drugs. The company was founded on February 24, 2015 and is headquartered in Incheon, South Korea.

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

The Korea Atomic Energy Research Institute (KAERI) in Daejeon, South Korea was established in 1959 as the sole professional research-oriented institute for nuclear power in South Korea, and has rapidly built a reputation for research and development in various fields. In 1995 KAERI designed and constructed the nation's first multipurpose research reactor, HANARO based on the Canadian MAPLE design. KAERI is dedicated to finding a wide range of uses for atomic energy. As examples, KAERI developed the world's first radiopharmaceutical "Milican injection" for treating liver cancer.

Nestec SA, a subsidiary of Nestlé SA, is a Swiss company located in Vevey. The firm manufactures nutrition food products.

UbiVac is a clinical-stage biotechnology company engaged in the research and development of therapeutic vaccines to combat cancer. Founded in Portland, OR in 2005 as a spinout of the Robert W. Franz Cancer Research Center within the Earle A. Chiles Research Institute, at Providence Portland Medical Center, UbiVac continues to build upon the groundbreaking research being developed in the region.

Chengdu West China Precision Medicine Industry Technology Research Institute Co., Ltd., established on 2017-05-27, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Health Consulting Services(Does not include medical services);Intellectual Property Services(Except for patent agency services);Technology intermediary service;Science popularization service;3Dprint service;business management;Corporate Headquarters Management;Production of Class I Medical Devices;Sales of Class I Medical Devices;Class I Medical Device Leasing;Sales of Class II Medical Devices;Class II Medical Device Leasing(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Class III Medical Device Leasing;Drug Clinical Trial Services(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments).

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Shanghai Chest Hospital is a Chinese company ultimately controlled by the Government of China. The firm specializes in treating cadio-vascular system, lungs, esophagus, trachea and mediastinum.

ITO Co., Ltd. engages in the manufacture and sale of hospital and home therapy, rehabilitation, health and beauty equipment. The company was founded by Kenji Ito in 1916 and is headquartered in Kawaguchi, Japan.

Xinghuozhiyao (Beijing) Technology Co., Ltd., established on 2017-05-09, Business scope includes technology development,Technology Promotion,technology transfer,technical consulting,Technical Services;Organize cultural and artistic exchange activities(without show);literary creation;Undertake exhibition and display activities;Conference Services;translation service;Computer System Services;Basic software service;Application software service(Does not contain medical software);product design;model design;Packaging and decoration design;Economic and Trade Consulting;public relations service;Conference Services;Fashion Design;Jewelry Design;arts and crafts design;computer graphic design,make;buisness planning;design,make,acting,Place an ad;market survey;Business Management Consulting;natural science research;Engineering and Technology Studies;Agricultural Science and Technology Research;Medical Research(Does not include medical activities);data processing(Bank Card Center in Data Processing,PUEvalue in1,5Except for the above cloud computing data centers);sell clothing,jewelry.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Heilongjiang Liansheng Biotechnology Co., Ltd., established on 2020-05-26, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Research and development of bio-based materials technology;Medical Research and Experimental Development;New material technology research and development;Development of Human Gene Diagnosis and Therapy Technology;R&D and application of cell technology;Sales of Class I Medical Devices;Chemical product sales(No licensed chemical products);Instrument sales;Disinfectant sales(Free of Hazardous Chemicals);Sales of hygiene products and single-use medical products;Sales of labor protection products;Personal Hygiene Sales;Drug testing equipment sales;Experimental analysis instrument sales;Office Supplies Sales;internet data service;Artificial intelligence public data platform;Big data service;Data processing and storage support services.

Medical & Biological Laboratories Co., Ltd. engages in the research, development, manufacture and sale of biological products. It operates through the Reagents and Investment segments. The Reagent segment supplies, manufactures, and sells clinical reagents and research reagents, and its related equipment and instruments. The Investment segment deals with investments on bio-related enterprises and mediates technical partnership. The company was founded on August 23, 1969 and is headquartered in Nagoya, Japan.

Pomerai (Changzhou) Biotechnology Co., Ltd., established on 2020-06-29, Business scope includes licensed projects:Sales of special products for computer information system security(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Information Technology Consulting Services;Intellectual Property Services;internet data service;Information system operation and maintenance services;Wholesale of computer software, hardware and auxiliary equipment;Cloud Computing Equipment Sales;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Internet of Things Technology Services;Biochemical product technology research and development;R&D of industrial enzyme preparations;Specialty Chemicals Sales(Free of Hazardous Chemicals);Engineering and Technology Research and Experimental Development;Artificial intelligence basic resources and technology platform;Development of Human Gene Diagnosis and Therapy Technology;Fermentation process optimization technology research and development;Medical Research and Experimental Development;Chemical product sales(No licensed chemical products);Experimental analysis instrument sales;Natural science research and experimental development;Extraction of marine bioactive substances,purification,Synthesis technology research and development;Agricultural Science Research and Experimental Development;Research and development of biopesticide technology;software sales;Blockchain technology related software and services;software development;Artificial intelligence basic software development;Artificial intelligence application software development;Software outsourcing service;Artificial intelligence theory and algorithm software development;Retailing of computer software, hardware and auxiliary equipment;Sales of industrial control computers and systems;Data processing and storage support services(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Liaocheng Aorun Biomedical Technology Co., Ltd., established on 2015-05-05, The scope of business includes engaging in technology research and development in the field of biomedical expertise,Technology Promotion,technical consulting,technology transfer,Technical Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China.

Zhejiang Sixian Pharmaceutical Co., Ltd., established on 1999-11-22, Business scope includes licensed projects:pharmaceutical production;Technology Import and Export;Import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Chemical product sales(No licensed chemical products);Food Additive Sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).